340B Drug Pricing Program Contributes to Rising Healthcare Costs and Is Ripe for Reform
The U.S. House Energy & Commerce Committee's Health Subcommittee today will host the third hearing in its health care affordability series, specifically examining the role providers and hospitals play in shaping the cost of care for Americans.
While the hearing will likely examine numerous issues, there is none more ripe for reform than the flawed 340B drug pricing program.
Originally enacted to help eligible safety-net providers buy medicines at steep discounts and pass the savings on to lower-income and vulnerable patients, the program has ballooned as a revenue stream for many participating hospitals and contract pharmacy chains.
As the size and complexity of the 340B program has expanded, participating hospitals and contract pharmacies have instead used the program to increase…[more]
"If you buy a car," White House press secretary Karine Jean-Pierre explained the other day, "you are expected to pay the monthly payment. ... It's that simple."
Is it? Now, obviously, those who argue that the president can cancel millions of student loans by decree aren't in a position to offer lessons on personal responsibility. The deeper problem with Jean-Pierre's analogy, though, is that there isn't a bank on Earth that's going to keep lines of credit open when a person is compounding unsustainable debt year after year.
Speaking of which, the federal government has already…
